Lasofoxifene May Reduce Breast Cancer Risk in Postmenopausal Osteoporotic Women
Links shared publicly online about this topic
Lasofoxifene reduces breast cancer risk in postmenopausal osteoporotic women
physorg.com — “Lasofoxifene statistically reduced the overall risk of breast cancer, as well as ER positive invasive breast cancer in postmenopausal women with low bone density, according to a study published online in The Journal of the National Cancer Institute.” View full resource at physorg.com
Most Recently Shared on November 4, 2010 at 9:53 pm By:
Lasofoxifene reduces breast cancer risk in postmenopausal osteoporotic women http://bit.ly/90St0o
Lasofoxifene Reduces Breast Cancer Risk in Postmenopausal Osteoporotic Women " J. Natl. Cancer Inst.
jnci.oxfordjournals.org — “Lasofoxifene Reduces Breast Cancer Risk in Postmenopausal Osteoporotic Women " J. Natl. Cancer Inst.” View full resource at jnci.oxfordjournals.org
Most Recently Shared on November 5, 2010 at 3:44 pm By:
J Nat'l Cancer Inst Medical Journal and Oncology
Study shows lasofoxifene reduces breast cancer risk in postmenopausal women. See press release. http://fb.me/x4zxFoL3
Third-Generation SERMs May Face Uphill Battle --" J. Natl. Cancer Inst.
jnci.oxfordjournals.org — “Third-Generation SERMs May Face Uphill Battle --" J. Natl. Cancer Inst.” View full resource at jnci.oxfordjournals.org
Most Recently Shared on November 11, 2010 at 3:13 pm By:
J Nat'l Cancer Inst Medical Journal and Oncology
Lasofoxifene, despite excellent clinical trial results, likely to face drug approval difficulties. News article... http://fb.me/L3z2ACce
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
FightCancer
Cancer news feed, formerly part of a blog. RSS suggestions welcome.
-
J Nat'l Cancer Inst
JNCI, an Oxford University Press journal, publishes peer-reviewed original research and is an internationally acclaimed source for cancer news and information.
-
J Nat'l Cancer Inst
JNCI, an Oxford University Press journal, publishes peer-reviewed original research and is an internationally acclaimed source for cancer news and information.
Advertisement
